InsidersTradesSigma
Roivant Sciences Ltd. Stock: price and management transactions · United States · SEC (Form 4)
Follow the Roivant Sciences Ltd. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Operating in the Health Care sector, Roivant Sciences Ltd. has logged 308 insider filings. Market capitalisation: €25.3bn. The latest transaction was reported on 30 June 2026 (Cession). Among the most active insiders: Venker Eric. The full history is openly available.
308
Insider Decl.
0
Thresholds
€20m
2 ops.
Buy Volume
€463m
61 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 16,836 of 25,791 companies
42.0
score / 100
Value27
Quality57
FCF yld-3.0%
Earn yld-1.2%
EV/EBITDA·
ROE-7.6%
Gross mgn84%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 30 June 2026
Declarations308 total
300,783 sharesCommon SharesSEC:0001193125-26-291163:0
325,000 sharesCommon SharesSEC:0001193125-26-291163:1
200,000 sharesCommon SharesSEC:0001193125-26-291163:2
600,000 sharesCommon SharesSEC:0001193125-26-291163:3
12,380 sharesCommon SharesSEC:0001193125-26-291163:4
300,783 sharesCommon SharesSEC:0001193125-26-291172:0
325,000 sharesCommon SharesSEC:0001193125-26-291172:1
200,000 sharesCommon SharesSEC:0001193125-26-291172:2
600,000 sharesCommon SharesSEC:0001193125-26-291172:3
12,380 sharesCommon SharesSEC:0001193125-26-291172:4
200,000 sharesCommon SharesSEC:0001193125-26-291172:5
1,653 shares@ US$10.622.0% of flowCommon SharesSEC:0001140361-25-020985:0
3,487 shares@ US$11.044.4% of flowCommon SharesSEC:0001140361-25-020242:0
39,148 shares@ US$11.042.5% of flowCommon SharesSEC:0001140361-25-020241:0
10,945 shares@ US$11.041.9% of flowCommon SharesSEC:0001140361-25-020240:0
273,959 shares@ US$11.474.4% of flowCommon SharesSEC:0001214659-25-007221:0
1,653 shares@ US$11.192.1% of flowCommon SharesSEC:0001140361-25-016748:0
141,464 shares0Common SharesSEC:0001140361-25-015254:0
10,945 shares@ US$10.151.7% of flowCommon SharesSEC:0001140361-25-014985:0
10,945 shares@ US$10.150.6% of flowCommon SharesSEC:0001140361-25-014986:0
1,379 shares0Common SharesSEC:0001140361-25-014801:0
1,847 shares0Common SharesSEC:0001140361-25-014802:0
1,653 shares@ US$10.382.1% of flowCommon SharesSEC:0001140361-25-011688:0
10,945 shares@ US$10.971.9% of flowCommon SharesSEC:0001140361-25-010117:0
25 of 308 declarations
About Roivant Sciences Ltd.
Roivant Sciences Ltd. is a biopharmaceutical company focused on developing innovative medicines to address unmet medical needs. It employs a technology-driven approach to accelerate the drug discovery and development process.